Ознакомительная версия. Доступно 17 страниц из 84
51 (8): 1307 – 1312, 2006.
143 Singh, M. et al., Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring) 21 (2): 284 – 90, 2012.
144 Berger, M. et al., The expanded biology of serotoni Annu Rev Med 60: 355 – 66, 2009.
145 Liu, Z. et al., Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr 94 (4): 386 – 93, 2005; Schulzke, J. D. et al., Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr Res 43: 435 – 441, 1998; Maes, M. et al., Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome. J Affect Disord 136 (3): 909 – 17, 2012; Caradonna, L. et al., Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6 (3): 205 – 14, 2000; Maes, M. et al., The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 29 (1): 117 – 24, 2008; Sapone, A. et al., Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 55 (5): 1443 – 49, 2006; Amery, W. K./Forget, P. P., The role of the gut in migraine: the oral 51-Cr EDTA test in recurrent abdominal pain. Cephalgia 9 (3): 227 – 29, 1989; Yacyshyn, D. et al., Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability. Dig Dis Sci 41 (12): 2493 – 98, 1996; Smith, M. et al., Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 12 (2): 299 – 305, 1985; Orr, J. S. et al., Large artery stiffening with weight gain in humans: role of visceral fat accumulation Hypertension 51 (6): 1519 – 24, 2008; Buchanan, M. M. et al., Toll-like receptor 4 in CNS pathologies. J Neurochem 114 (1): 13 – 27, 2010.
146 Wenn Sie dieses Thema ausführlich vertiefen wollen, empfiehlt sich als Literatur mein Buch SCHLANK! und gesund mit der Doc Fleck Methode, Hilden: BJV Verlag 2017.
147 Keshavarzian, A. et al., Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol 50 (3): 538 – 47, 2009.
148 Draper, A. J./Hammock, B. D., Identification of CYP2C9 as a human liver microsomal linoleic acid epoxygenase. Arch Biochem Biophys 376 (1): 199 – 205, 2000.
149 Dethlefsen, L. et al., The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6 (11): e280, 2008.
150 Farhadi, A. et al., Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int 28 (7): 1026 – 33, 2008. Campanella, C./Jamali, F., Influence of prolonged exposure of a short half life non-steroidal anti-inflammatory drugs on gastrointestinal safety. Inflammopharmacology 17 (4): 205 – 10, 2009.
151 Watanabe, T. et al., Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 57 (2): 181 – 87, 2008.
152 Whitehead, M. W. et al., Mechanisms of aluminum absorption in rats. Am J Clin Nutr 65 (5): 1446 – 52, 1997.
153 Zhang, Y. et al., Effects of iron overload on the bone marrow microenvironment in mice. PLoS ONE 10 (3): e0120219, 2015.
154 John, S. et al., Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol 22 (5): 602 – 606, 2010.
155 Romano, C. et al., Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn’s disease: a double-blind, randomized, placebo-controlled study. World J Gastroenterol 11 (45): 7118 – 121, 2005.
156 Centers for Disease Control and Prevention. Siehe http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.Html. Updated October 24, 2014. Abgerufen am 7. September 2018.
157 Diabetes Facts and Figures; International Diabetes Foundation. Siehe http://www.idf.org/about-diabetes/facts-figures. Abgerufen am 7. Juli 2018.
158 Dabelea, D. et al., Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311 (17): 1778 – 1786, 2014.
159 Dean, H./Flett, B., Natural history of type 2 diabetes diagnosed in childhood: Long term follow-up in young adult years. Diabetes 51 (s1): A24-A25, 2002.
160 Cali, A. M./Caprio, S., Prediabetes and type 2 diabetes in youth: an emerging epidemic disease? Curr Pin Endocrinol Diabetes Obes 15 (2): 123 – 127, 2008.
161 Le Stunff, C. et al., The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity. Nature Genetics 26 (4): 444 – 446, 2000; Sigal, R. J. et al., Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study. Diabetes 46 (6): 1025 – 1029, 1997.
162 Hansen, J. B. et al., Inhibition of insulin secretion as a new drug target in the treatment of metabolic disorders. Current Medicinal Chemistry 11 (12): 1595 – 1615, 2004; Mitri, J./Hamdy, O., Diabetes medications and body weight. Expert Opinion on Drug Safety 8 (5): 573 – 584, 2009.
163 Tabák, A. G. et al., Prediabetes: a high-risk state for diabetes development. Lancet 379 (9833): 2279 – 90, 2012.
164 Suez, J. et al., Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514 (7521): 181 – 86, 2014.
165 Feinman, A. D. et al., Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition 31 (1): 1 – 13, 2015.
166 Udupa, A. et al., A comparative study of effects of omega-3 Fatty acids, alpha lipoic Acid and vitamin e in type 2 diabetes mellitus. Ann Med Health Sci Res 3 (3): 442 – 446, 2013.
167 Samimi, M. et al., Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial. Clin Nutr. pii: S0261–5614(14)00169–1. Epub 17. Juni 2014.
168 Moosheer, S. M. et al., A protein-enriched low glycemic index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes. Prim Care Diabetes 8 (4): 308 – 14, 2014.
169 Zhang, M. et al., Fish and marine omega-3 polyunsatured Fatty Acid consumption
Ознакомительная версия. Доступно 17 страниц из 84
